Ferroxidases in RPE Iron Transport

RPE 铁转运中的铁氧化酶

基本信息

  • 批准号:
    7650575
  • 负责人:
  • 金额:
    $ 39.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-08-01 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Iron is necessary in the retina for oxidative phosphorylation, membrane biogenesis and retinol isomerization, but can also produce oxidative stress if improperly regulated, leading to cell death. This can contribute to retinal disease as follows: 1) Iron toxicity causes rapid retinal degeneration following direct entry of iron into the eye carried by an intraocular foreign body. 2) Human AMD retinas have more iron than age-matched controls, suggesting that iron overload may play a role in AMD pathogenesis. 3) Inherited defects in the ferroxidase ceruloplasmin (Cp) result in retinal iron accumulation and early onset macular degeneration. 4) Mice with mutation in Cp and its homolog hephaestin (Heph) have an age-dependent retinal iron overload and degeneration with a number of features similar to AMD, including subretinal neovascularization. The latter two points indicate that Cp and Heph are important for retinal health. Evidence from other organs suggests that Cp or Heph can cooperate with the plasma membrane iron transporter ferroportin (Fpn) to export iron from cells. The goal of this proposal is to increase understanding of the roles of Cp, Heph and Fpn in retinal iron homeostasis and their regulation by the secreted hormone hepcidin (Hepc). Hepc is produced in the retina (as well as the liver) and triggers internalization and degradation of Fpn. Hepc may serve as a message from retinal cells sensing iron excess (such as photoreceptors) to degrade Fpn and limit iron transfer from RPE and Muller cells. Our existing Cp/Heph double mutant and Hepc-/- mice indicate that these three proteins are critical for retinal iron homeostasis and health, but provide little information about the specific functions of the proteins within the retina. Conditional mouse knockout technology (lox/cre) affords the opportunity to determine how these proteins function within specific retinal cell types and how intercellular iron transfer is executed and regulated. In Aim1, the photoreceptor-specific functions of Heph, a possible "iron release valve" to prevent PR iron overload will be investigated using a Heph conditional knockout on a Cp-/- background. In Aim 2, the iron transport function of Fpn will be investigated using RPE and photoreceptor-specific conditional knockout mice. In Aim 3, the retinal function of Hepc will be investigated in knockout and conditional knockout mice. These studies are important because: 1) They will provide new information about the cell-type specific functions of Heph, Fpn and Hepc and the routes of intercellular iron transfer that control retinal iron homeostasis. 2) The conditional knockout mice are likely to provide models for several features of AMD, including subretinal neovascularization while avoiding the lifespan-limiting brain iron overload in our existing Cp/Heph double mutant mice. PUBLIC HEALTH RELEVANCE: The proposed work on the mechanisms of retinal iron transport is relevant to retinal health since iron overload has been implicated in age-related macular degeneration (AMD) and other retinal diseases. The mouse models resulting from mutation of iron transporters are expected, based on our previous work, to have features of AMD, including subretinal neovascularization, photoreceptor and RPE death, lipofuscin accumulation, and activation of the complement cascade. These models will provide a platform for understanding the mechanisms of retinal iron regulation and testing potential therapeutics for retinal disease.
描述(由申请人提供):铁在视网膜中是氧化磷酸化、膜生物发生和视黄醇异构化所必需的,但如果调节不当,也会产生氧化应激,导致细胞死亡。这可能导致视网膜疾病如下:1)铁毒性在由眼内异物携带的铁直接进入眼睛后引起快速视网膜变性。2)人类AMD视网膜比年龄匹配的对照组具有更多的铁,这表明铁过载可能在AMD发病机制中起作用。3)铁氧化酶铜蓝蛋白(Cp)的遗传缺陷导致视网膜铁积累和早发性黄斑变性。4)具有Cp及其同源物肝啡肽(Heph)突变的小鼠具有年龄依赖性视网膜铁过载和退化,具有许多类似于AMD的特征,包括视网膜下新生血管形成。后两点表明Cp和Heph对视网膜健康很重要。来自其他器官的证据表明,Cp或Heph可以与质膜铁转运蛋白(Fpn)合作,从细胞中输出铁。该提案的目标是增加对Cp,Heph和Fpn在视网膜铁稳态中的作用及其由分泌激素铁调素(Hepc)调节的理解。Hepc在视网膜(以及肝脏)中产生,并触发Fpn的内化和降解。Hepc可以作为来自视网膜细胞的信息,感知铁过量(如光感受器),以降解Fpn并限制来自RPE和Muller细胞的铁转移。我们现有的Cp/Heph双突变体和Hepc-/-小鼠表明,这三种蛋白质对视网膜铁稳态和健康至关重要,但对视网膜内蛋白质的特定功能提供的信息很少。条件性小鼠基因敲除技术(lox/cre)提供了确定这些蛋白质在特定视网膜细胞类型中如何发挥作用以及细胞间铁转移如何执行和调节的机会。在Aim 1中,将使用Cp-/-背景下的Heph条件性敲除研究Heph的光受体特异性功能,Heph是防止PR铁过载的可能的“铁释放阀”。在目标2中,将使用RPE和光感受器特异性条件性敲除小鼠研究Fpn的铁转运功能。在目标3中,将在基因敲除和条件性基因敲除小鼠中研究Hepc的视网膜功能。这些研究具有重要意义,因为:1)它们将提供有关Heph、Fpn和Hepc的细胞类型特异性功能以及控制视网膜铁稳态的细胞间铁转移途径的新信息。2)条件性基因敲除小鼠可能为AMD的几个特征提供模型,包括视网膜下新生血管形成,同时避免我们现有的Cp/Heph双突变小鼠中的寿命限制性脑铁过载。公共卫生关系:由于铁超载与年龄相关性黄斑变性(AMD)和其他视网膜疾病有关,因此拟议的关于视网膜铁转运机制的工作与视网膜健康相关。基于我们先前的工作,预期由铁转运蛋白突变产生的小鼠模型具有AMD的特征,包括视网膜下新生血管形成、光感受器和RPE死亡、脂褐素积累和补体级联激活。这些模型将为理解视网膜铁调节机制和测试视网膜疾病的潜在治疗方法提供平台。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSHUA L DUNAIEF其他文献

JOSHUA L DUNAIEF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSHUA L DUNAIEF', 18)}}的其他基金

The IL-6 Induced Retinal Iron Sequestration Response
IL-6 诱导的视网膜铁螯合反应
  • 批准号:
    10416008
  • 财政年份:
    2019
  • 资助金额:
    $ 39.38万
  • 项目类别:
The IL-6 Induced Retinal Iron Sequestration Response
IL-6 诱导的视网膜铁螯合反应
  • 批准号:
    10281696
  • 财政年份:
    2019
  • 资助金额:
    $ 39.38万
  • 项目类别:
The IL-6 Induced Retinal Iron Sequestration Response
IL-6 诱导的视网膜铁螯合反应
  • 批准号:
    10636913
  • 财政年份:
    2019
  • 资助金额:
    $ 39.38万
  • 项目类别:
Novel Iron Prochelators for Protection Against Oxidative Stress in RPE Cells
用于保护 RPE 细胞免受氧化应激的新型铁预螯合剂
  • 批准号:
    7451925
  • 财政年份:
    2008
  • 资助金额:
    $ 39.38万
  • 项目类别:
Novel Iron Prochelators for Protection Against Oxidative Stress in RPE Cells
用于保护 RPE 细胞免受氧化应激的新型铁预螯合剂
  • 批准号:
    7577522
  • 财政年份:
    2008
  • 资助金额:
    $ 39.38万
  • 项目类别:
Retinal iron transport in health and disease
健康和疾病中的视网膜铁转运
  • 批准号:
    8662780
  • 财政年份:
    2004
  • 资助金额:
    $ 39.38万
  • 项目类别:
PENN Vision Clinical Scientist Program
PENN Vision 临床科学家计划
  • 批准号:
    10643842
  • 财政年份:
    2004
  • 资助金额:
    $ 39.38万
  • 项目类别:
Ferroxidases in RPE iron transport
RPE 铁转运中的铁氧化酶
  • 批准号:
    6826940
  • 财政年份:
    2004
  • 资助金额:
    $ 39.38万
  • 项目类别:
Retinal Iron Transport in Health and Disease
健康和疾病中的视网膜铁转运
  • 批准号:
    10327706
  • 财政年份:
    2004
  • 资助金额:
    $ 39.38万
  • 项目类别:
Ferroxidases in RPE iron transport
RPE 铁转运中的铁氧化酶
  • 批准号:
    6931023
  • 财政年份:
    2004
  • 资助金额:
    $ 39.38万
  • 项目类别:

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    $ 39.38万
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    $ 39.38万
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 39.38万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 39.38万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 39.38万
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    $ 39.38万
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    $ 39.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 39.38万
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    $ 39.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了